Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Adaptive Randomization of Neratinib in Early Breast Cancer.
Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial.
Principal Investigator
The Role of Immunotherapy in Triple-Negative Breast Cancer (TNBC).
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Principal Investigator
Overview
researcher role of
Gilliam, Melissa
contributes to
Developing a method to increase HIV testing among YMSM